Temporada, Cemarmimi .

HRN: 26-17-35  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/12/2024
CEFUROXIME 1.5GM (VIAL)
12/12/2024
12/12/2024
IVT
1.5grams
Loading Dose
For CS
Waiting Final Action 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

 Final appropriateness: Yes     

 Overall appropriateness: Yes